Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Basal Insulin and Basal-Bolus Therapy in Patients with Type 2 Diabetes Based on Attainment of Clinically Relevant Treatment Targets
Cannon, Anthony J., Bargiota, Alexandra, Billings, Liana, Hunt, Barnaby, Leiter, Lawrence A., Malkin, Samuel, Mocarski, Michelle, Ranthe, Mattis Flyvholm, Schiffman, Alisa, Doshi, AnkurLanguage:
english
Journal:
Journal of Managed Care & Specialty Pharmacy
DOI:
10.18553/jmcp.2019.19035
Date:
December, 2019
File:
PDF, 306 KB
english, 2019